期刊文献+

rhBMP-7对小鼠骨髓间充质干细胞向成骨细胞分化的影响 被引量:5

Effects of rhBMP-7 on osteoblast differentiation of murine bone marrow mesenchymal stem cells in vitro
下载PDF
导出
摘要 目的:观察重组人骨形成蛋白-7(rhBMP-7)对小鼠骨髓间充质干细胞(BMSCs)向成骨细胞分化的影响。方法:采用密度梯度离心法分离骨髓,体外培养扩增,获得小鼠骨髓间充质干细胞,贴壁培养至第3代,向培养液中加入rhBMP-7,培养5 d后进行碱性磷酸酶(ALP)染色,ALP活性与骨钙素(OC)含量检测,并用RT-PCR法分析成骨细胞标志基因骨钙素(OC)与Ⅰ型胶原(Col-Ⅰ)表达情况,Western blot法检测Ⅰ型胶原(Col-Ⅰ)蛋白的分泌量。结果:rhBMP-7诱导组的骨髓间充质干细胞的ALP染色强度、ALP活性及OC含量明显升高,OC与Col-Ⅰ的mRNA表达水平以及Col-Ⅰ的蛋白表达水平均明显提高。结论:rhBMP-7可促进体外培养的小鼠BMSCs向成骨细胞方向分化。 AIM: To study the effects of recombinant human bone morphogenetic protein-7 (rhBMP-7) on osteo- blast differentiation of murine bone marrow mesenchymal stem cells (BMSCs). METHODS: The BMSCs were collected from murine bone marrow by density gradient centrifugation. Cells were adherent cultured and expanded in vitro. RhBMP-7 was added into the culture medium of the 3rd passage BMSCs. Five days later, we performed alka- line phosphatase (ALP) staining and detected ALP activity and osteocalcin (OC) content. Osteoblast differentiation marker gene including OC and collage Ⅰ (Col-Ⅰ ) were assayed by RT-PCR. Total protein was isolated and the secretion of Col- Ⅰ in the cells was measured by Western blotting. RESULTS: The staining intensity of ALP in the group with rhBMP-7 was stronger than that in the negative control group. ALP activity and OC content of rhBMP-? group were obviously higher than that of the negative control group. The mRNA of OC and Col-Ⅰ and the protein of Col-Ⅰwere highly expressed in the group induced by rhBMP-7. CONCLUSION: RhBMP-7 can induce murine BMSCs to differentiate into osteoblast in vitro.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2012年第10期1025-1028,共4页 Chinese Journal of Cellular and Molecular Immunology
基金 国家高技术研究发展计划(863)资助项目(2003AA2Z3532) 安徽高校省级自然科学研究项目(KJ2009B154)
关键词 重组人骨形成蛋白-7 小鼠 骨髓间充质干细胞 成骨分化 recombinant human bone morphogeneticprotein-7 mouse bone marrow mesenchymalstem cells osteogenic differentiation
  • 相关文献

参考文献16

  • 1Asahina I,Sampath TK,Hauschka PV. Human osteogenic protein-1induces chondroblastic,osteoblastic, and/or adipocytic differentiationof clonal murine target cells[ J].Exp Cell Res, 1996, 222( 1) : 38 -47.
  • 2Park BW, Hah YS, Kim DR, et al. Osteogenic phenotypes andmineralization of cultured human periosteal-derived cells [ J ]. ArchOral Biol, 2007,52(10) ; 983 -989.
  • 3Cheline AJ, Reddi AH, Marlin RB. Bone morphogenetic protein-7selectively enhances mechanically induced bone formation [ J] ? Bone,2002, 31(5) : 570-574.
  • 4Lissenberg-Thunnissen SN,de Gorter DJ, Sier CF, et al. Use andefficacy of bone morphogenetic proteins in fracture healing [ J].IntOrthop, 2011,35(9) : 1271 -1280.
  • 5车婧,韩金祥,王世立,梁浩.重组人成骨蛋白-1在大肠杆菌中的高效表达及复性[J].中国药学杂志,2005,40(13):1023-1026. 被引量:8
  • 6王国栋,王世立,韩金祥,张翠,张更林,车婧.表达重组人骨形态发生蛋白-7工程菌的发酵及表达产物的纯化[J].生物技术通讯,2006,17(3):345-348. 被引量:4
  • 7Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesen-chymal stem cells derived from adult marrow [ J ]. Nature, 2002, 18(6893): 41 -49.
  • 8范萍,刘永琦,吴晓晶,董介正,颜春鲁,张毅,苏菊萍.不同条件下骨髓间充质干细胞分离培养及其生物学特性研究[J].细胞与分子免疫学杂志,2010,26(4):322-324. 被引量:17
  • 9邱曙东,宋天宝.组织化学和免疫组织化学[M].北京:科学出版社,2008: 79 -81.
  • 10Khaled EG, Saleh M, Hindocha S, et al. Tissue engineering forbone production-stem cells,gene therapy and scaffolds [ J ]. OpenOrthop J,2011, 5 SuppI 2 ; 289 -295.

二级参考文献80

  • 1王国栋,王世立,韩金祥.骨形态发生蛋白-7的研究进展[J].医学分子生物学杂志,2004,1(6):382-385. 被引量:6
  • 2刘品端,王伟,梅晰凡.大鼠骨髓间充质干细胞的分离与培养贴壁分离和消化控制相结合可否为简便高效的技术方法[J].中国临床康复,2005,9(18):38-40. 被引量:9
  • 3Maegawa N, Kawamura K, Hirose M, et al. Enhancement of osteoblastic differentiation of mesenchymal stromal cells cultured by selective combination of bone morphogenetic protein-2 (BMP-2) and fibroblast growth factor-2 ( FGF-2 ) [ J ]. J Tissue Eng Regen Med, 2007, 1(4) : 306 -313.
  • 4Varkey M, Kucharski C, Haque T, et al. In vitro osteogenic response of rat bone marrow cells to bFGF and BMP-2 treatments[ J]. Clin Orthop Relat Res, 2006, 443(2) : 113 -123.
  • 5Solchaga LA, Penick K, Porter JD, et al. FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells[ J ]. J Cell Physiol, 2005, 203 (2) : 398 - 409.
  • 6Zhang X, Sobue T, Hurley MM. FGF-2 increases colony formation, PTH receptor, and IGF-1 mRNA in mouse marrow stromal cells [ J ]. Biochem Biophys Res Commun, 2002, 290(1 ): 526-531.
  • 7Dupree MA, Pollack SR, Levine EM, et al. Fibroblast growth factor 2 induced proliferation in osteoblasts and bone marrow stromal cells: a whole cell model[J]. Biophys J, 2006, 91(8) : 3097 -3112.
  • 8Winer J, Jung CK, Shackel I, et al. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro [ J ]. Anal Biochem, 1999, 270(1) : 41 -49.
  • 9Urist MR. Bone formation by autoinduction, Science, 1965, 150(3698): 893-899.
  • 10Wozney JM, Rosen V, Celeste A J, et al. Novel regulators of bone formation: molecular clones and activities, Science, 1988, 242(4885): 1528-1534.

共引文献49

同被引文献56

  • 1Chang J, Liu F, Lee M, et al. NF-KB inhibits osteogenic differenti- ation of mesenchymal stem ceils by promoting β-catenin degradation [J]. Proc Natl Acad Sci U S A, 2013, 110(23) : 9469 -9474.
  • 2Chen BY, Wang X, Chen LW, et al. Molecular targeting regulation of proliferation and differentiation of the bone marrow-derived mesenchymal stem cells or mesenchymal stmmal cells[ J]. Curt Drug Targets, 2012, 13(4) : 561 -571.
  • 3Zhong Y, Xu J, Deng M, et al. Generation of a human bone marrow-derived mesenchymal stem cell line expressing and secreting high levels of bioactive et-melanocyte-stimulating hormone [ J ]. J Biochem, 2013, 153(4): 371 -379.
  • 4Akiyama K, Chen C, Wang D, et al. Mesenchymal-stem-cell- induced immunoregulation involves FAS-ligand-/FAS-mediated T cell apoptosis[J]. Cell Stem Cell, 2012, 10(5) : 544 -555.
  • 5Davatchi F, Nikbin B, Shams H, et al. Mesenchymal stem cell therapy unable to rescue the vision from advanced Behcet's disease retinal vasculitis : report of three patients [ J ]. Int J Rheum Dis, 2013, 16(2) : 139 -147.
  • 6Ganji MR. Postmenopausal osteoporosis treatment and risk of urinary calculus developmen[J]. Iran J Kidney Dis, 2013, 7(3) : 171 - 174.
  • 7Wood CL, Wood AM, Harker C, et al. Bone mineral density and osteoporosis after preterm birth: the role of early life factors and nutrition[J/OA]. Int J Endocrinol, 2013, 2013: 902513.
  • 8Avsar U, Karakus E, Halici Z, et al. Prevention of bone loss by Panax ginseng in a rat model of inflammation-induced bone loss[J]. Cell Mol Biol (Noisy-le-grand), 2013, 59 (Suppl) : 0L1835- OL1841.
  • 9Yang N, Wang G, Hu C. Tumor necrosis factor ot suppresses the mesenchymal stem cell osteogenesis promoter miR-21 in estrogen deficiency-induced osteoporosis [ J ]. J Bone Miner Res, 2013, 28(3) : 559 - 573.
  • 10Reid IR. Osteoporosis treatment: Focus on safety [ J ]. Eur J Intern Med, 2013 Apr 19. doi: pii: S0953 - 6205 (13) 00096 - 4.10. 1016/. ejim. 2013.03. 012. [ Epub ahead of print].

引证文献5

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部